J Korean Radiol Soc.  1985 Dec;21(6):849-857. 10.3348/jkrs.1985.21.6.849.

Transcatheter hepatic artery embolization of liver cancer

Abstract

From March 1985 to Sep.1985, Transcatheter hepatic arterial embolization was perfromed in 17 primary heptomaand 8 metstasis of liver in Department of Radiology, Yonsei University College of Medicine. Metastatic cancers ofliver were one nasopharyngeal cancer, one small bowel leiomyosarcoma, one gall bladder cancer and 5 colon cancers.The used embolization materials were the followings: Gelfoam particles for one primary hepatoma, 95% absoluteethanol for 4 patients, Ivalon(250-590micro m) for 19 patients and autologous blood clots for one metastasis, Theresults were summarized as the follows: 1. The devascularization of tumor vessels in post-emblization hepaticangiogram was complete in 6 primary hepatom and one metastasis and partial in 11 primary hepatoma and 7metastasis. 2. In the follow-up CT evaluation 3 to 4 weeks after embolization, well necrotic density was revealedin 8 primary hepatoma and one metastasis. 3. The complications were fever with higher than 38 degrees C(92%),abdominal pain (72%) and nausia or vomiting(40%). They were subsided wtihin one to 7 days after embolization. 4.In liver function study, sGOT and sGPT were elevated in 80% of total cases and returned to normal within 15 to 30days. LDH was variable. In 4 cases of absolute ethanol infusion, above liver enzymes were markedly elvated as 10times or more as normal range.


MeSH Terms

Alanine Transaminase
Aspartate Aminotransferases
Carcinoma, Hepatocellular
Colon
Ethanol
Fever
Follow-Up Studies
Gallbladder Neoplasms
Gelatin Sponge, Absorbable
Hepatic Artery*
Humans
Leiomyosarcoma
Liver Neoplasms*
Liver*
Nasopharyngeal Neoplasms
Neoplasm Metastasis
Reference Values
Alanine Transaminase
Aspartate Aminotransferases
Ethanol
Full Text Links
  • JKRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr